MAP2K7 and neoplasm: They suggested that an arylsulfonamide structure was a suitable scaffold to attach to the E3 ligase ligand for MEK degradation and developed compound 3 as an effective MEK1 degrader (IC50 = 0.1 μM) to inhibit tumor proliferation [77].